Don't want ads? Subscribe or login now.

CVS Can't Escape FCA Suit Alleging Drugmaker Collusion

By Daniel Wilson · March 13, 2023, 11:01 PM EDT

A Pennsylvania federal judge has refused to dismiss a whistleblower False Claims Act suit accusing CVS units of colluding with drugmakers to keep Medicare beneficiaries from accessing certain generic drugs, finding...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Opinion

Case Information

Case Title

ELLSWORTH ASSOCIATES, LLP et al v. CVS HEALTH CORPORATION et al

Case Number

2:19-cv-02553

Court

Pennsylvania Eastern

Nature of Suit

Qui Tam (31 U.S.C. § 3729(a))

Date Filed

June 12, 2019

Recent Articles By Daniel

April 29, 2024
GSA Guides Agencies On Responsible Generative AI Buying
April 25, 2024
DOL Wage Trumps Local Pay Rate For FDA Contract, Board Rules
March 25, 2024
Gorsuch Irked At Having To Decide $3K Furlough Dispute
February 20, 2024
Amentum Can Claim Some COVID Leave Costs From Air Force
February 16, 2024
DOL To Appeal Disclosure Of Contractor Demographic Reports
January 31, 2024
Contractors In GOP States To Face Brunt Of Pay Equity Plan
January 01, 2024
Government Contracts Cases To Watch In 2024: A Preview
December 21, 2023
FAR Council Finalizes Labor Deal Rule For Construction Work
December 19, 2023
Top Government Contracting Policies Of 2023: Year In Review
November 13, 2023
Gov't Arguing 'Nonsense' Over FCA Settlement, 5th Circ. Told